Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure

Al-Saeedi, Mohammed and Steinebrunner, Niels and Kudsi, Hassan and Halama, Niels and Mogler, Carolin and Buechler, Markus W. and Krammer, Peter H. and Schemmer, Peter and Mueller, Martina (2018) Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure. CELL DEATH & DISEASE, 9: 132. ISSN 2041-4889,

Full text not available from this repository. (Request a copy)

Abstract

Ischemia-reperfusion injury is a common pathological process in liver surgery and transplantation, and has considerable impact on the patient outcome and survival. Death receptors are important mediators of ischemia-reperfusion injury, notably the signaling pathways of the death receptor CD95 (Apo-1/Fas) and its corresponding ligand CD95L. This study investigates, for the first time, whether the inhibition of CD95L protects the liver against ischemia-reperfusion injury. Warm ischemia was induced in the median and left liver lobes of C57BL/6 mice for 45 min. CD95Fc, a specific inhibitor of CD95L, was applied prior to ischemia. Hepatic injury was assessed via consecutive measurements of liver serum enzymes, histopathological assessment of apoptosis and necrosis and caspase assays at 3, 6, 12, 18 and 24 h after reperfusion. Serum levels of liver enzymes, as well as characteristic histopathological changes and caspase assays indicated pronounced features of apoptotic and necrotic liver damage 12 and 24 h after ischemia-reperfusion injury. Animals treated with the CD95L-blocker CD95Fc, exhibited a significant reduction in the level of serum liver enzymes and showed both decreased histopathological signs of parenchymal damage and decreased caspase activation. This study demonstrates that inhibition of CD95L with the CD95L-blocker CD95Fc, is effective in protecting mice from liver failure due to ischemia-reperfusion injury of the liver. CD95Fc could therefore emerge as a new pharmacological therapy for liver resection, transplantation surgery and acute liver failure.

Item Type: Article
Uncontrolled Keywords: RECEPTOR-MEDIATED APOPTOSIS; ISCHEMIA/REPERFUSION INJURY; MOUSE-LIVER; FAS LIGAND; HEPATOCELLULAR-CARCINOMA; WARM ISCHEMIA; P53 FAMILY; RAT-LIVER; IN-VIVO; KAPPA-B;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 20 Mar 2020 14:58
Last Modified: 20 Mar 2020 14:58
URI: https://pred.uni-regensburg.de/id/eprint/15177

Actions (login required)

View Item View Item